글로벌 소아 신경교종 약물 시장 – 2030년까지의 산업 동향 및 예측

소아 신경교종 약물 시장 분석 및 규모

글로벌 소아 신경교종 약물 시장은 예측 기간 동안 상당한 성장을 보일 것으로 예상됩니다. 소아 종양 사례는 전 세계적으로 증가하고 있으며, 이는 시장 성장으로 이어지고 있습니다. 첨단 진단 기술과 새로운 치료법도 시장의 주요 원동력입니다. 특히 아시아 태평양 지역에서 소아 신경교종의 새로운 사례가 빠르게 증가하고 있습니다. 게다가 의료 부문 개선, 공중 보건 개선을 위한 정부 이니셔티브, 의료 지출 증가로 소아 신경교종 약물 시장 성장이 촉진되고 있습니다.

Data Bridge Market Research는 2023-2030년 예측 기간 동안 글로벌 소아 신경교종 약물 시장의 성장률을 분석합니다. 글로벌 소아 신경교종 약물 시장의 예상 CAGR은 언급된 예측 기간 동안 약 6.50%인 경향이 있습니다. 시장은 2022년에 10억 2천만 달러로 평가되었으며 2030년까지 17억 달러까지 성장할 것입니다. Data Bridge Market Research 팀이 큐레이팅한 시장 보고서에는 시장 가치, 성장률, 시장 세그먼트, 지리적 범위, 시장 참여자 및 시장 시나리오와 같은 시장 통찰력 외에도 심층적인 전문가 분석, 환자 역학, 파이프라인 분석, 가격 분석 및 규제 프레임워크가 포함되어 있습니다.

소아 신경교종 약물 시장 범위 및 세분화

Market Definition

Paediatric gliomas is a type of disorder that is characterized by the tumour of spinal cord or brain in children. It starts in glial cells that are present around the neurons, generating electrical impulses to transmit information, commonly known as glioma tumour. Moreover, the tumour causes complete damage in infratentorial brain functioning, including the brainstem and cerebellum. The most common symptoms in gliomas tumours include vomiting, headache, nausea, vision problems, and seizures.

Global Paediatric Gliomas Drugs Market Dynamics

Drivers

• Increase in Paediatric Population

The geriatric population is expected to increase the patient population globally, which boots the global paediatric gliomas drugs market in the forecast period. Currently, there are an estimated 2 billion children in the world ages zero to 14-years-old. This boost the market growth.

• Rising Demand for Oral Drugs

Oral drugs is projected to boost the market growth. The segment is expected to accelerate the global market as most products are available in capsule and tablet form and it is a very viable route of administration.

Opportunities

• Increased Cases of Glioma

As per the records of the Case Reports in Oncology, 2018, around 200 cases were recorded globally for glioblastoma multiforme. Consequently, the market gains more attention and the growth is high because of the higher incidence of this diseased condition.

• Rising Healthcare Awareness

Health awareness amongst the population are rising, resulting in the prediction of drugs to boost market growth. The innovative launches in medications for the treatment of paediatric gliomas are expected to prompt the market simultaneously. Different researchers are investing in launching drugs that benefit the market. This creates more opportunities in the market.

Restraints/Challenges

• Lack of Skilled Professionals

Lack of trained professionals who are unaware of the treatment methods for this disease could limit the growth of the global paediatric gliomas drugs market over a forecast period.

• High Cost

The huge expenditure of the treatment methods hamper the market growth. Several treatments and diagnostic procedures involve high cost that somewhat impedes market growth.

This global paediatric gliomas drugs market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global paediatric gliomas drugs market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Paediatric Gliomas Drugs Market Scope

The global paediatric gliomas drugs market is segmented on the basis of type, diagnosis, treatment, distribution channel and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

• Low Grade
• High Grade

Diagnosis

• Imaging Test
• Brain or Spinal Cord
• Tumour Biopsy
• Others

Treatment

• Surgery
• Drug Treatments
• Therapies

End-Users

• Hospitals
• Homecare
• Speciality Centres
• Others

Distribution Channel

• Hospital Pharmacy
• Online Pharmacy
• Retail Pharmacy

 Paediatric Gliomas Drugs Market Regional Analysis/Insights

The global paediatric gliomas drugs market is analyzed and market size insights and trends are provided by type, diagnosis, treatment, distribution channel and end-user as referenced above.

The major countries covered in the global paediatric gliomas drugs market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America is expected to have the highest market growth due to the presence of key manufacturers of the product is high and, increasing research and development activities, healthcare expenditure.  

Asia-Pacific dominates the market due to increased government awareness programs and number of generic drugs.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Competitive Landscape and Global Paediatric Gliomas Drugs Market Share Analysis

The global paediatric gliomas drugs market overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to global paediatric gliomas drugs market.

Key players operating in the global paediatric gliomas drugs market include:

• Mylan N.V. (U.S.)
• Teva Pharmaceutical Industries Ltd.(Israel)
• Sanofi (France)
• Pfizer Inc. (U.S.)
• Novartis AG (Switzerland)
• Bayer AG (Germany)
• Merck & Co., Inc. (U.S.)
• Allergan (Ireland)
• AstraZeneca (U.K.)
• Abbott (U.S.)
• Bausch Health Companies Inc. (Canada)
• Sun Pharmaceutical Industries Ltd. (India)
• Aurobindo Pharma (India)
• Lupin (India)
• Amneal Pharmaceuticals LLC. (U.S.)
• Thermo Fisher Scientific Inc. (U.S.)
• Baxter (U.S.)
• Hitachi, Ltd (Japan)
• Siemens Healthcare GmbH (Germany)
• Konninklije Philips N.V. (Netherlands)

Research Methodology: Global Paediatric Gliomas Drugs Market

Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Customization Available

Data Bridge Market Research는 고급 형성 연구 분야의 선두 주자입니다. 저희는 기존 및 신규 고객에게 목표에 맞는 데이터와 분석을 제공하는 것을 자랑으로 생각합니다. 보고서는 타겟 브랜드의 가격 추세 분석, 추가 국가에 대한 시장 이해(국가 목록 요청), 임상 시험 결과 데이터, 문헌 검토, 재생 시장 및 제품 기반 분석을 포함하도록 사용자 정의할 수 있습니다. 타겟 경쟁업체의 시장 분석은 기술 기반 분석에서 시장 포트폴리오 전략까지 분석할 수 있습니다. 필요한 만큼 많은 경쟁업체를 원하는 형식과 데이터 스타일로 추가할 수 있습니다. 저희 분석가 팀은 또한 원시 Excel 파일 피벗 테이블(팩트북)로 데이터를 제공하거나 보고서에서 사용할 수 있는 데이터 세트에서 프레젠테이션을 만드는 데 도움을 줄 수 있습니다.

SKU-56017